McKesson Corporation (MCK) has been at the center of investor attention with several financial opinions pointing towards a solid value stock for the long-term. Despite underperforming its competitors and the pharma sector, the company's stock has consistently trended upwards. Notwithstanding a few dips, MCK's stock price outperformed the broader market and has hit multiple all-time highs. The company's
first quarter fiscal 2026 earnings have received attention for their performance on key metrics, contributing to the continued interest in the stock. In 2025, Francisco Fraga joined as Executive Vice President, Chief Information Officer and Chief Technology Officer. Mckesson's
Q1 earnings beat estimates, with the company subsequently raising its 2026 EPS view. Despite this, the stock was down following the announcement. Thanks to its strong financial performance, such as record revenue, MCK’s shares have soared, although there was a notable drop below the 200-day moving average. McKesson is planning to spin off its
Medical-Surgical Solutions business, considered by many as a positive move. The company has also completed the acquisition of PRISM Vision Holdings, which may bolster its growth.
Mckesson Corporation MCK News Analytics from Mon, 04 Nov 2024 08:00:00 GMT to Thu, 14 Aug 2025 06:35:38 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor -3
